NCT06920758Active, not recruiting
A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Active, not recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Ablon Skin Institute Research Center
- Participants (registry)
- 60
- Start
- December 2024
- Primary completion
- September 2025
- Study completion
- September 2025
- Last registry update
- April 2025
- Countries
- United States
Conditions studied: Thinning Hair
Interventions: USPlus DERM Bioactive Fatty Acids 160 mg Softgels, Placebo softgel
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.